Adrenal and Paraganglionic Tumors
Adrenal and Paraganglionic Tumors is a research topic within Surgery. Science Explorer counts 24k research works in it since 1950. 13.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the research related to pheochromocytoma and paraganglioma, including genetic mutations, clinical management, adrenal incidentalomas, biochemical diagnosis, succinate dehydrogenase, adrenocortical carcinoma, imaging characteristics, and molecular classification.
- Pheochromocytoma
- Paraganglioma
- Genetic Mutations
- Clinical Management
- Adrenal Incidentaloma
- Biochemical Diagnosis
- Succinate Dehydrogenase
- Adrenocortical Carcinoma
- Imaging Characteristics
- Molecular Classification
- Research works
- 24k fractional, since 1950
- In the world top 10%
- 3.1k per year above
- Top-10% rate
- 13.0% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +25% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Adrenal and Paraganglionic Tumors research?
By volume, the United States and China publish the most (926 and 582 works in 2022–2025).
By volume, 2022–2025
- 1 United States 926 works
- 2 China 582 works
- 3 India 231 works
- 4 Japan 228 works
- 5 Italy 202 works
- 6 Germany 155 works
- 7 Spain 130 works
- 8 Türkiye 128 works
- 9 United Kingdom 123 works
- 10 France 121 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Adrenal and Paraganglionic Tumors research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Adrenal and Paraganglionic Tumors research, followed by Peking Union Medical College Hospital and The University of Texas MD Anderson Cancer Center.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 33 works
- 2 Peking Union Medical College HospitalChina 24 works
- 3 The University of Texas MD Anderson Cancer CenterUnited States 17 works
- 4 Cleveland ClinicUnited States 17 works
- 5 All India Institute of Medical SciencesIndia 16 works
- 6 University of PaduaItaly 16 works
- 7 Mayo Clinic in ArizonaUnited States 14 works
- 8 Mayo ClinicUnited States 14 works
- 9 University of MichiganUnited States 13 works
- 10 Capital Medical UniversityChina 13 works
Who are the leading researchers in Adrenal and Paraganglionic Tumors?
The most-cited researchers publishing on Adrenal and Paraganglionic Tumors include Martin Schlumberger and Fred Saad.
- 1 Martin Schlumberger France 3.1k citations
- 2 Fred Saad Canada 2.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Adrenal and Paraganglionic Tumors research done?
The largest centres of Adrenal and Paraganglionic Tumors research in 2022–2025 are Beijing (China), Tokyo (Japan), Paris (France) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Bethesda.
Largest cities, 2022–2025
Where it is the local speciality
- BethesdaUS · 34.4 works7.1×
Location quotient: how much more of its research is in Adrenal and Paraganglionic Tumors than the world average.
Where is the best place to study Adrenal and Paraganglionic Tumors?
Among universities, judged by research, University of Turin, Chinese Academy of Medical Sciences & Peking Union Medical College and University of Padua score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | University of TurinItaly | 58.2 | 38.5% | 6.3× | 12 | -6.3% |
| 2 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 56.2 | 11.0% | 8.7× | 33 | +25.2% |
| 3 | University of PaduaItaly | 48.8 | 19.3% | 5.1× | 16 | +49.9% |
| 4 | University of Naples Federico IIItaly | 48.4 | 33.4% | 3.9× | 9 | +65.3% |
| 5 | Ludwig-Maximilians-Universität MünchenGermany | 47.7 | 28.9% | 4.8× | 12 | -2.6% |
| 6 | Medical University of WarsawPoland | 47.2 | 20.2% | 10.2× | 9 | +8.8% |
| 7 | Chongqing Medical UniversityChina | 46.6 | 20.8% | 8.1× | 10 | — |
| 8 | Capital Medical UniversityChina | 43.7 | 12.1% | 5.6× | 13 | +137.2% |
| 9 | Stanford UniversityUnited States | 35.9 | 21.7% | 2.1× | 10 | +74.4% |
| 10 | Post Graduate Institute of Medical Education and ResearchIndia | 33.0 | 1.8% | 9.0× | 12 | +23.2% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Adrenal and Paraganglionic Tumors research growing?
Output in 2018–2022 was 25% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Adrenal and Paraganglionic Tumors.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.